AI assistant
Sending…
DEXCOM INC — Director's Dealing 2016
May 17, 2016
30198_dirs_2016-05-17_b331a241-97e1-4e7d-b75a-e47750e64a3e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2016-05-16
Reporting Person: GREGG TERRANCE H (Director, Executive Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-05-16 | Common Stock | S | 20000.0 | $62.718 | Disposed | 237464 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 472991 | Direct |
| Common Stock | 11461 | Indirect |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $62.58 to $62.92. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F2: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.
More from DEXCOM INC
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 15
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 17